Monografie
Can a regulatory instrument promote research and development into neglected diseases? A Policy Delphi Survey
- Sprache
-
Englisch
- Anmerkungen
-
Bielefeld, Univ., Diss., 2012
- Identifier
-
1027249485
Thema
Arzneimittelentwicklung; Arzneimitteldesign; Hochschulschrift
Beteiligte Personen und Organisationen
Fehr, Angela
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:56 MEZ
Objekttyp
- Monografie
Beteiligte
- Fehr, Angela
Ähnliche Objekte (12)
IAP antagonism as a novel approach to target endothelial activation
The study of substance use in longitudinal research
In silico drug discovery on computational grids for finding novel drugs on neglected diseases
New approaches to improve prediction of drug-induced liver injury
Modellierung molekularer und makromolekularer Zustände im geleiteten strukturbasierten virtuellen Screening
Activity-based sulfatase and affinity-based metalloprotease probes: ready for take-off
Therapeutic concepts : Proposing a new regulatory pathway for combination therapies
Entwicklung eines Screening-Tests und Schwellen-Tests zur Prüfung des Schmecksinns
Structure-based development of secondary amines as aspartic protease inhibitors
Insights into binding of attachment factors and inhibitors to a human norovirus from NMR and SPR experiments
Insights into Biomolecular Structure from Theoretical Spectroscopy
Aktives Targeting non-viraler siRNA-basierter Gentransfersysteme zur Therapie des alveolären Rhabdomyosarkoms
IAP antagonism as a novel approach to target endothelial activation
The study of substance use in longitudinal research
In silico drug discovery on computational grids for finding novel drugs on neglected diseases
New approaches to improve prediction of drug-induced liver injury
Modellierung molekularer und makromolekularer Zustände im geleiteten strukturbasierten virtuellen Screening
Activity-based sulfatase and affinity-based metalloprotease probes: ready for take-off
Therapeutic concepts : Proposing a new regulatory pathway for combination therapies
Entwicklung eines Screening-Tests und Schwellen-Tests zur Prüfung des Schmecksinns
Structure-based development of secondary amines as aspartic protease inhibitors
Insights into binding of attachment factors and inhibitors to a human norovirus from NMR and SPR experiments
Insights into Biomolecular Structure from Theoretical Spectroscopy
Aktives Targeting non-viraler siRNA-basierter Gentransfersysteme zur Therapie des alveolären Rhabdomyosarkoms
IAP antagonism as a novel approach to target endothelial activation
The study of substance use in longitudinal research
In silico drug discovery on computational grids for finding novel drugs on neglected diseases
New approaches to improve prediction of drug-induced liver injury
Modellierung molekularer und makromolekularer Zustände im geleiteten strukturbasierten virtuellen Screening
Activity-based sulfatase and affinity-based metalloprotease probes: ready for take-off
Therapeutic concepts : Proposing a new regulatory pathway for combination therapies
Entwicklung eines Screening-Tests und Schwellen-Tests zur Prüfung des Schmecksinns
Structure-based development of secondary amines as aspartic protease inhibitors
Insights into binding of attachment factors and inhibitors to a human norovirus from NMR and SPR experiments
Insights into Biomolecular Structure from Theoretical Spectroscopy